Heather Burns

Dr. Heather Burns

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2022 in Vaccine
Verified
Journal Article
Closed access
RCRuth Ceannt
Ruth Ceannt
FVFrédérique Vallières
Frédérique Vallières
HBHeather Burns
Heather Burns
JMJamie Murphy
Jamie Murphy
PHPhilip Hyland
Philip Hyland

29 January 2020 in European Journal of Public Health
Verified
Journal Article
Closed access
HBHeather E Burns
Heather E Burns
ACAbigail M Collins
Abigail M Collins
UFUna B Fallon
Una B Fallon
PMPaul V Marsden
Paul V Marsden
CSCaitlin M Ni Shuilleabhain
Caitlin M Ni Shuilleabhain
Background: Rotavirus vaccine efficacy is well established. However, it is important to consistently demonstrate the positive impact of vaccination programmes in order to optimize uptake rates and combat vaccine hesitancy. Methods: Routine data were used to examine rotavirus vaccine effectiveness in Ireland, including changes in age-specific crude incidence rates (CIRs), hospitalizations and hospital length of stay. National intussusception incidence was interrogated. Vaccination status of vaccine-eligible cases of rotavirus infection was determined. Results: Nationally, a reduction in the CIR of rotavirus infection of 77.2% [95% confidence interval (CI) 57.8–88.5%, P<0.001] was observed post-inclusion of the rotavirus vaccine in the primary immunization schedule. A decrease in hospitalizations of 85.5% (95% CI 79.3–90.2%, P<0.001), 86.5% (95% CI 82.9–89.4%, P<0.001) and 78.5% (95% CI 74.7–81.9%, P<0.001) was observed in children aged <1, <2 and <5 years, respectively. Most hospitalizations occurred in infants too young to have been vaccinated. There was no significant difference in median length of stay for children hospitalized with rotavirus infection. Decreased CIRs and hospitalization rates in unvaccinated children aged between 2 and 5 years suggest community immunity. Vaccine non-protection was 0.13%. No increase in the national CIR of intussusception was observed. Conclusions: Inclusion of the rotavirus vaccine in the Irish primary immunization schedule has resulted in a significant reduction in the burden of rotavirus infection. However, vaccine hesitancy remains a concern. With new vaccination programmes, risk of vaccine harms should be considered and mitigated in order to protect individuals and the integrity of the programme.

10 August 2021 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
HBHeather Burns
Heather Burns
ACAbigail Collins
Abigail Collins
PMPaul Marsden
Paul Marsden
TFTerence J. Flood
Terence J. Flood
MSMary A. Slatter
Mary A. Slatter
TLTimothy Ronan Leahy
Timothy Ronan Leahy

Verified
Journal Article
Open access
PDF file
MBMargaret Brennan
Margaret Brennan
AOAoife O'Connell
Aoife O'Connell
LGLoretta O Grady
Loretta O Grady
MEMohamed Elsammak
Mohamed Elsammak
JBJennifer J Brady
Jennifer J Brady
ACAbigail Collins
Abigail Collins
Severe combined immunodeficiency (SCID) and spinal muscular atrophy (SMA) are being added to the Newborn Bloodspot Screening (NBS) programme in the Republic of Ireland. To support this expansion, we conducted a scoping review to identify reported timeframes for implementing national, regional or state-wide expanded NBS programmes. We performed a scoping review of the literature published between 2015 and 2025. Eligible articles described the timeframes for implementation of expanded NBS programmes for SCID, SMA or additional metabolic conditions. Sources included PubMed, Embase, citation searching, the International Journal of Neonatal Screening and grey literature. A narrative synthesis was undertaken. Fourteen articles met the inclusion criteria, describing the addition of new conditions—SCID (N = 7), SMA (N = 4), or multiple conditions (N = 3) to expanded NBS programmes in the United States (US), Europe (Belgium, Catalonia, the Czech Republic, Estonia, Germany, Norway, Poland, Portugal, Slovakia, Slovenia, Sweden, and Tuscany), Hong Kong and New Zealand. In most jurisdictions, the implementation of NBS programmes for new conditions took two to six years. The implementation of NBS for new conditions requires considerable time and coordinated efforts. Further research providing greater detail on the specific implementation steps, along with associated timelines, would provide valuable guidance for jurisdictions aiming to expand NBS programmes globally.

Verified
Journal Article
Open access
PDF file
MBMairead Bracken-Scally
Mairead Bracken-Scally
AOAnna O'Loughlin
Anna O'Loughlin
HBHeather Burns
Heather Burns
The aim of the evaluation was to gather information on parents’ experiences and attitudes towards the Irish National Newborn Bloodspot Screening Programme (NNBSP). An interviewer-administered survey was completed by 151 parents whose babies underwent newborn bloodspot screening (NBS) between 2023 and 2025 and for whom the screening result was normal. Results suggest that NBS is highly acceptable to parents, with 100% glad their baby underwent screening. The majority (95%) felt they were provided the information needed to understand the importance of NBS for their baby, and 93% are in favour of screening for more conditions. Positive aspects of NBS reported by parents included the following: blood sampling being undertaken in the home, the sample-taker being very nice and being advised in advance to keep the baby’s heel warm to ease the sampling process. Negative aspects of NBS reported included the following: having to return to the hospital for sampling, the baby becoming distressed, not receiving adequate information and not receiving the screening results. Parents were more likely to report negative experiences if the sample was not taken at home and if the sample was taken by a healthcare professional other than a public health nurse. Parents offered recommendations for improvements to the programme. This study provides important insights into parents’ experiences and attitudes towards NBS in Ireland.

16 January 2025 in Irish Journal of Medical Science (1971 -)
Verified
Journal Article
Open access
PDF file
SOSean O’rEgan
Sean O’rEgan
JAJack Adams
Jack Adams
BJBenjamin M. Jacob
Benjamin M. Jacob
HBHeather Burns
Heather Burns
PRPatrick Redmond
Patrick Redmond